Mandate

Vinge has assisted in connection with Samhällsbyggnadsbolaget’s listing on Nasdaq Stockholm

September 26, 2019 Capital Markets and Public M&A

Vinge has assisted with counselling on securities law and transaction execution in connection with Samhällsbyggnadsbolaget i Norden AB (publ)’s list change of their B‑ and D‑shares from Nasdaq First North Premier Growth Market to Nasdaq Stockholm’s main market.

The prospectus was published on 18 September 2019 and the trading on Nasdaq Stockholm commenced 20 September 2019.

The company’s strategy is to own, manage and develop community service properties throughout the Nordic region and rental apartments in growth regions in Sweden. As of 30 June 2019, the
property portfolio consisted of 790 properties with a reported amount for investment properties totalling SEK 30.3 billion.

Vinge’s team has primarily consisted of Jesper Schönbeck, Malte Hedlund, Boris Kotur, Anders Sundin Lundberg and Nils Fredrik Dehlin. Maria Schultzberg, Victor Ericsson and Henrik Wastenson advised on tax issues.

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025